Samuel Agus | Chief Medical Officer

Samuel Agus, Chief Medical Officer, Biophytis

Samuel Agus has served as our Chief Medical Officer since July 2018. From April 2017 to June 2018 he served as Vice President, Chief Medical Officer of Hansa Medical AB (Publ), a biotechnology company. Prior to that, he served at various leadership positions in clinical development and medical affairs, in several pharmaceutical companies, such as Teva Pharmaceuticals industries, Solvay Pharmaceuticals, Abbott, Shire and H. Lundbeck A/S. Dr. Agus holds a doctorate in Medicine from The Hebrew University of Jerusalem. He is a board-certified neurologist (from Israel) and has had academic training in biostatistics and bioinformatics.


World Orphan Drug Congress USA 2019 - Day 2 @ 14:30

Pitch 24: Re-thinking clinical trial design in DMD

last published: 20/Mar/19 21:45 GMT

back to speakers